Home » Topics » BioWorld Science

BioWorld Science
RSS

European Commission approves Xeljanz for active psoriatic arthritis

June 29, 2018

Researchers present preclinical data for [11C]NOP-46

June 29, 2018

Kymab to test KY-1044 in combination with atezolizumab in clinical trials

June 29, 2018

Melinta Therapeutics describes leads from the pyrrolocytosine class of antibiotics

June 29, 2018

Akebia Therapeutics and Keryx Biopharmaceuticals sign definitive merger agreement

June 29, 2018

Efficacy unclear in study of mutated IDH1 peptide vaccine in patients with gliomas

June 29, 2018

Enrollment begins in phase IIa study of CC-31244 for the treatment of HCV-infected individuals

June 29, 2018

Preliminary data presented from the PIVOT-02 study of NKTR-214 plus nivolumab

June 29, 2018

Erimos Pharmaceuticals initiates phase I study of oral terameprocol

June 29, 2018

Inovio reports phase I results for INO-4700 in MERS

June 29, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...